Ulcer: Clinical Trials

46 trials for Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 6 terminated, 4 unknown, 2 suspended. 46 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 346Completed 30, Terminated 6, Unknown 4, Suspended 2, Withdrawn 2, Not yet recruiting 1, Recruiting 1
Phase 26Completed 3, Recruiting 1, Suspended 1, Terminated 1

Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer

Trials (filtered) newest first · largest first

All 46 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With Cirrhosis
Vonoprazan, Rabeprazol - Endoscopic Variceal Band Ligation
Phase 3Not yet recruitingKing George's Medical University3002026-05-012026-05-27
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3RecruitingWest China Hospital322025-01-012026-09-21
A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis
MEBO Wound Ointment (MEBO), Tantum Verde® mouthwash - Oral Mucositis (Ulcerative) Due to Radiation
Phase 3CompletedCairo University362023-03-012025-09-22
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
NL003, Normal Saline - Arterial Occlusive Disease, Ischemia
Phase 3CompletedBeijing Northland Biotech. Co., Ltd.2422019-08-282024-09-20
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
NL003, Normal Saline - Arterial Occlusive Disease, Ischemia
Phase 3CompletedBeijing Northland Biotech. Co., Ltd.3022019-08-022024-09-19
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Ozanimod, Placebo - Colitis, Ulcerative
Phase 3CompletedCelgene1982019-06-032025-10-15
Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting
Curcumin Lozenges, Placebo Lozenges - Oral Mucositis (Ulcerative)
Phase 3UnknownTata Memorial Centre1902018-12-162023-11-24
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Cisplatin, Intensity Modulated Radiation Therapy, Ulinastatin - Oral Mucositis (Ulcerative) Due to Radiation
Phase 3CompletedSun Yat-sen University1792018-01-302026-05-07
A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
adalimumab - Pyoderma Gangrenosum
Phase 3CompletedAbbVie222017-10-272021-03-09
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
Intrastromal voriconazole, Natamycin - Corneal Ulcer, Fungal Keratitis
Phase 3CompletedUniversity of California, San Francisco702016-09-012025-09-25
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
LT-02, LT-02 Placebo - Ulcerative Colitis
Phase 3TerminatedPrometheus Laboratories252016-07-012017-06-15
Cross-linking for Corneal Ulcers Treatment Trial
Corneal Cross-linking, Anti Fungal Drug - Corneal Ulcer, Infectious Keratitis
Phase 3CompletedUniversity of California, San Francisco1472015-11-012025-06-18
Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers
Allogeneic cord blood platelet gel-CBPG, Standard Local Medications-SLM - Diabetic Foot Ulcers
Phase 3CompletedCentro Nazionale Sangue502015-01-012017-07-21
PRP ULCERAS: Clinical Trial Phase III
Platelet-Rich Plasma, Usual treatment - Ulcer
Phase 3WithdrawnBasque Health Service2015-01-012020-02-25
A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane
Amniotic Membrane - Epidermolysis Bullosa Dystrophica, Recessive, Ulcer
Phase 3UnknownAssistance Publique - Hôpitaux de Paris222015-01-012016-11-04
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
HP802-247, HP802-247 Vehicle - Venous Ulcer, Venous Stasis Ulcer
Phase 3TerminatedHealthpoint2522013-11-012016-10-03
Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment
Pedyphar Ointment, Panthenol - Diabetic Foot Ulcer
Phase 3CompletedEuropean Egyptian Pharmaceutical Industries802013-04-012015-03-05
Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding
Misoprostol, Placebo - Ulcer Hemorrhage
Phase 2 / Phase 3CompletedChinese University of Hong Kong822013-04-012019-01-31
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
Electrohydraulic-generated shock wave, Sham device plus standard of care - Diabetic Foot Ulcers
Phase 3UnknownSANUWAVE, Inc.902013-03-012014-03-06
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
HP802-247, Vehicle - Venous Leg Ulcers
Phase 3CompletedHealthpoint1552012-11-012017-07-26

Showing 20 of 46. Sign in to see all of them.

Narrower conditions

Diabetic Foot (10)  ·  Colitis (7)  ·  Colitis, Ulcerative (7)  ·  Gastrointestinal Diseases (6)  ·  Colonic Diseases (5)  ·  Diabetes Mellitus (5)  ·  Inflammatory Bowel Diseases (5)  ·  Digestive System Diseases (4)  ·  Gastroenteritis (4)  ·  Intestinal Diseases (4)  ·  Pathologic Processes (4)  ·  Proctitis (4)  ·  Proctocolitis (4)  ·  Varicose Ulcer (4)

Broader conditions

Pathological Conditions, Signs and Symptoms (46)  ·  Pathologic Processes (42)  ·  Skin and Connective Tissue Diseases (21)  ·  Skin Diseases (19)  ·  Cardiovascular Diseases (16)  ·  Vascular Diseases (16)  ·  Skin Ulcer (15)  ·  Leg Ulcer (14)  ·  Diabetes Complications (10)  ·  Diabetic Angiopathies (10)  ·  Endocrine System Diseases (10)  ·  Foot Ulcer (10)  ·  Diabetic Neuropathies (9)  ·  Digestive System Diseases (9)  ·  Gastrointestinal Diseases (7)

Interventions

Mesalamine (3)  ·  Budesonide (2)  ·  Ibuprofen (2)  ·  Ofloxacin (2)  ·  Saline Solution (2)  ·  pexiganan (2)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Acyclovir (1)  ·  Adalimumab (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Biological Dressings (1)  ·  Calcium Dobesilate (1)  ·  Cisplatin (1)  ·  Collagenases (1)  ·  Corneal Cross-Linking (1)

Sponsors

Bausch Health Americas, Inc. (3)  ·  Healthpoint (3)  ·  Abeona Therapeutics, Inc (2)  ·  Amgen (2)  ·  Beijing Northland Biotech. Co., Ltd. (2)  ·  University of California, San Francisco (2)  ·  AbbVie (1)  ·  Actelion (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azidus Brasil (1)  ·  Basque Health Service (1)  ·  Bayer (1)  ·  BioSyntech Canada Inc. (1)  ·  Cairo University (1)  ·  Celgene (1)

Countries

United States (17)  ·  Canada (6)  ·  China (5)  ·  India (5)  ·  Poland (5)  ·  Spain (5)  ·  France (3)  ·  Germany (3)  ·  Hungary (3)  ·  Italy (3)  ·  Japan (3)  ·  Russia (3)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Colombia (2)

Top investigators

Tommy Lee, MSHS (3)  ·  Herbert B Slade, MD (2)  ·  Paul Litka, MD (2)  ·  Robert Kirsner, MD (2)  ·  William Marston, MD (2)  ·  Alberto Restrepo, M.D. (1)  ·  Arturo Orduz, MD (1)  ·  Barbara Latenser, MD (1)

Results publications

PMID 29037354, PMID 18990064, PMID 25644096, PMID 26165391, PMID 27416045, PMID 11396765, PMID 15504999, PMID 17897470, PMID 18601587, PMID 19064169, PMID 19128245, PMID 19152653, PMID 19170984, PMID 19424751, PMID 19715417, PMID 20074379, PMID 20443734, PMID 20873963, PMID 21155009, PMID 21896561, PMID 21947706, PMID 23180507, PMID 23736928, PMID 2403699, PMID 25547983, PMID 25583938, PMID 25951490, PMID 25995322, PMID 27163986, PMID 28614248, PMID 29739175, PMID 29966612, PMID 30944817, PMID 31619359, PMID 31786695, PMID 32088712, PMID 32289853, PMID 32557558, PMID 33031809, PMID 33079921, PMID 33141449, PMID 35024776, PMID 35044972, PMID 35120736, PMID 3753059, PMID 37975046, PMID 42427283

NIH funding

2014 (1)